Ishita Drugs and Industries Limited (ISHITADR.BO)
INR 75.91
(-6.86%)
INR 75.91
(-6.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.96 Million INR | 25.98% |
| 2022 | 6.32 Million INR | -34.21% |
| 2021 | 9.61 Million INR | 24.57% |
| 2020 | 7.71 Million INR | 31.75% |
| 2019 | 5.85 Million INR | 62.69% |
| 2018 | 3.6 Million INR | 38.72% |
| 2017 | 2.59 Million INR | 17.68% |
| 2016 | 2.2 Million INR | 82.69% |
| 2015 | 1.2 Million INR | -60.78% |
| 2014 | 3.07 Million INR | 11.54% |
| 2013 | 2.75 Million INR | -24.83% |
| 2012 | 3.67 Million INR | 8.62% |
| 2011 | 3.38 Million INR | -44.48% |
| 2010 | 6.08 Million INR | 12.08% |
| 2009 | 5.43 Million INR | 55.68% |
| 2008 | 3.48 Million INR | -6.58% |
| 2007 | 3.73 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.45 Million INR | -48.21% |
| 2023 Q4 | 2.81 Million INR | 44.76% |
| 2023 Q1 | 1.34 Million INR | -35.36% |
| 2023 Q2 | 1.86 Million INR | 38.73% |
| 2023 FY | 7.96 Million INR | 25.98% |
| 2023 Q3 | 1.94 Million INR | 4.52% |
| 2022 Q2 | 1.06 Million INR | -43.68% |
| 2022 Q3 | 1.3 Million INR | 23.19% |
| 2022 Q4 | 2.07 Million INR | 58.84% |
| 2022 FY | 6.32 Million INR | -34.21% |
| 2022 Q1 | 1.88 Million INR | -60.1% |
| 2021 Q4 | 4.72 Million INR | 130.09% |
| 2021 Q1 | 1.42 Million INR | -52.75% |
| 2021 Q2 | 1.41 Million INR | -0.89% |
| 2021 Q3 | 2.05 Million INR | 45.14% |
| 2021 FY | 9.61 Million INR | 24.57% |
| 2020 Q3 | 1.97 Million INR | -0.13% |
| 2020 FY | 7.71 Million INR | 31.75% |
| 2020 Q4 | 3.01 Million INR | 53.02% |
| 2020 Q2 | 1.97 Million INR | 56.44% |
| 2020 Q1 | 1.26 Million INR | -39.6% |
| 2019 FY | 5.85 Million INR | 62.69% |
| 2019 Q4 | 2.09 Million INR | 14.93% |
| 2019 Q3 | 1.81 Million INR | 3.5% |
| 2019 Q2 | 1.75 Million INR | 4.55% |
| 2019 Q1 | 1.68 Million INR | -2.71% |
| 2018 Q2 | 1.1 Million INR | -3.17% |
| 2018 Q4 | 1.72 Million INR | 49.25% |
| 2018 FY | 3.6 Million INR | 38.72% |
| 2018 Q1 | 1.13 Million INR | -46.89% |
| 2018 Q3 | 1.15 Million INR | 5.15% |
| 2017 Q2 | 742 Thousand INR | -5.19% |
| 2017 Q1 | 782.6 Thousand INR | -38.72% |
| 2017 FY | 2.59 Million INR | 17.68% |
| 2017 Q4 | 2.14 Million INR | 179.87% |
| 2017 Q3 | 765 Thousand INR | 3.1% |
| 2016 Q1 | 497 Thousand INR | -60.99% |
| 2016 FY | 2.2 Million INR | 82.69% |
| 2016 Q2 | 476 Thousand INR | -4.23% |
| 2016 Q4 | 1.27 Million INR | 67.37% |
| 2016 Q3 | 763 Thousand INR | 60.29% |
| 2015 FY | 1.2 Million INR | -60.78% |
| 2015 Q4 | 1.27 Million INR | 185.65% |
| 2015 Q3 | 446 Thousand INR | 491.51% |
| 2015 Q1 | 687 Thousand INR | 518.32% |
| 2015 Q2 | 75.4 Thousand INR | -89.02% |
| 2014 Q2 | 1.15 Million INR | 192.62% |
| 2014 Q1 | 393 Thousand INR | 362.83% |
| 2014 FY | 3.07 Million INR | 11.54% |
| 2014 Q4 | -164.22 Thousand INR | -110.32% |
| 2014 Q3 | 1.59 Million INR | 38.43% |
| 2013 Q3 | 431 Thousand INR | -59.76% |
| 2013 Q2 | 1.07 Million INR | -18.24% |
| 2013 Q4 | -149.52 Thousand INR | -134.69% |
| 2013 Q1 | 1.31 Million INR | -41.36% |
| 2013 FY | 2.75 Million INR | -24.83% |
| 2012 Q1 | 1.15 Million INR | -2.46% |
| 2012 Q4 | 2.23 Million INR | 44.78% |
| 2012 FY | 3.67 Million INR | 8.62% |
| 2012 Q3 | 1.54 Million INR | 3.42% |
| 2012 Q2 | 1.49 Million INR | 29.63% |
| 2011 FY | 3.38 Million INR | -44.48% |
| 2011 Q4 | 1.18 Million INR | 28.26% |
| 2011 Q3 | 920 Thousand INR | 0.0% |
| 2010 Q4 | 2.8 Million INR | 0.0% |
| 2010 FY | 6.08 Million INR | 12.08% |
| 2009 Q4 | 2.14 Million INR | 0.0% |
| 2009 FY | 5.43 Million INR | 55.68% |
| 2008 Q4 | 805 Thousand INR | 0.0% |
| 2008 FY | 3.48 Million INR | -6.58% |
| 2007 FY | 3.73 Million INR | 0.0% |
| 2007 Q4 | 1.3 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -1398.308% |
| Sastasundar Ventures Limited | -229.64 Million INR | 103.47% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 121.103% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 91.925% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 86.997% |
| Sunil Healthcare Limited | -19.98 Million INR | 139.878% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 51.518% |
| MedPlus Health Services Limited | 1.31 Billion INR | 99.396% |
| Zenith Healthcare Limited | 196 Thousand INR | -3965.306% |
| Patidar Buildcon Limited | -1.83 Million INR | 533.987% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 87.641% |
| Roopa Industries Limited | 48.05 Million INR | 83.42% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Trident Lifeline Limited | 72.21 Million INR | 88.966% |
| Bacil Pharma Limited | -1.89 Million INR | 520.621% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 105.336% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | 11.368% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 104.978% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 53.472% |
| PANJON LTD. | - INR | -Infinity% |
| Tyche Industries Limited | 111.22 Million INR | 92.836% |
| Trimurthi Limited | -6.14 Million INR | 229.708% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 144.472% |
| Anuh Pharma Limited | 682.19 Million INR | 98.832% |
| Crestchem Limited | 27.25 Million INR | 70.766% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 167.784% |
| Zenlabs Ethica Limited | 89.27 Million INR | 91.075% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 97.653% |
| ANG Lifesciences India Limited | 12.8 Million INR | 37.774% |
| Parmax Pharma Limited | 3.75 Million INR | -112.223% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 97.813% |
| Deccan Health Care Limited | 185.32 Million INR | 95.701% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 96.627% |
| Norris Medicines Limited | 11.15 Million INR | 28.584% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 96.306% |
| Veerhealth Care Limited | 34.19 Million INR | 76.696% |
| Makers Laboratories Limited | -34.91 Million INR | 122.824% |
| Lactose (India) Limited | 137.78 Million INR | 94.217% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 106.448% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 98.176% |
| Mercury Laboratories Limited | 62.14 Million INR | 87.179% |
| Gennex Laboratories Limited | 146.61 Million INR | 94.565% |
| PRAVEG LIMITED | 185.06 Million INR | 95.695% |
| Denis Chem Lab Limited | 142.87 Million INR | 94.423% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 98.409% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 98.809% |
| Colinz Laboratories Limited | 14.64 Million INR | 45.585% |
| Godavari Drugs Limited | -67.67 Million INR | 111.775% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 2062.562% |
| Zenotech Laboratories Limited | 242.37 Million INR | 96.713% |
| Panchsheel Organics Limited | 288.28 Million INR | 97.236% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 98.608% |
| Vivanza Biosciences Limited | 14.83 Million INR | 46.278% |
| Phaarmasia Limited | - INR | -Infinity% |
| Bharat Parenterals Limited | 733.49 Million INR | 98.914% |
| Medi-Caps Limited | -17.21 Million INR | 146.299% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 85.173% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 99.067% |
| BDH Industries Limited | 169.01 Million INR | 95.286% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 178.526% |
| Coral Laboratories Limited | 142.63 Million INR | 94.414% |
| Concord Drugs Limited | 24.87 Million INR | 67.964% |
| Beryl Drugs Limited | 14.73 Million INR | 45.914% |
| Evoq Remedies Limited | 42.91 Million INR | 81.434% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 89.728% |
| Transchem Limited | -17.43 Million INR | 145.691% |
| Parnax Lab Limited | 166.84 Million INR | 95.224% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 76.671% |
| Kerala Ayurveda Limited | 48.04 Million INR | 83.416% |
| Cian Healthcare Limited | 53.96 Million INR | 85.236% |
| Trinity League India Limited | 1.17 Million INR | -579.284% |
| Syschem (India) Limited | 504.91 Million INR | 98.422% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 421.29% |
| Natural Capsules Limited | 112.4 Million INR | 92.911% |
| Auro Laboratories Limited | 95.77 Million INR | 91.681% |